Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy
Triple-negative breast cancers have a poor prognosis and are not amenable to endocrine- or HER2-targeted therapies. The prevailing view is that targeting the insulin-like growth factor (IGF) signal transduction pathway will not be beneficial for triple-negative breast cancers because their growth i...
Main Authors: | Zoë Davison, Gail E. de Blacquière, Bruce R. Westley, Felicity E.B. May |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-06-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558611800424 |
Similar Items
-
A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors
by: Rosalyne L. Westley, et al.
Published: (2013-01-01) -
Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
by: Kim Jung, et al.
Published: (2010-09-01) -
Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
by: Lee Jeong, et al.
Published: (2011-01-01) -
Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort
by: Homero Gonçalves, et al.
Published: (2018-07-01) -
Triple-Negative Breast Cancer Survival in Iranian Patients
by: Mahdi Aghili, et al.
Published: (2013-08-01)